Clinical trial
Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused…
NCT00003252 · Rush North Shore Medical Center, Other · Completed
Key facts
| NCT number | NCT00003252 |
|---|---|
| Title | Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy |
| Official title | A Phase IV Open Label Study of the Effects of a Five Minute Infusion Time for Ethyol (Amifostine) in Patients Undergoing Chemotherapy |
| Lead sponsor | Rush North Shore Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Drug/Agent Toxicity by Tissue/Organ, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | amifostine trihydrate |
| Start date | Dec 1, 1997 |
| Completion | Sep 1, 2004 |
| First posted | Sep 10, 2004 |
| Last update posted | Mar 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: